<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-NGA-T-LSMOH</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Accelerating TB case notification in Lagos State</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Nigeria - Tuberculosis - Lagos State Ministry of Health - LSMOH.  This program has the following goals: To accelerate efforts at ending TB epidemic in Nigeria by ensuring access to comprehensive and high quality patients&apos; centered and community owned TB (TB. TB/HIV and DR-TB) services for all Nigerians by 2025. The objectives of this program are: To increase case notification rate of all forms of TB from 60/100,000 population in 2019 to 153/100,000 population in 2023.  To increase TB treatment success rate from 87% in 2019 to 90% in 2023 among drug susceptible patients.  To enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2023</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Nigeria</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Nigeria</narrative>
  </participating-org>
  <participating-org role="3" type="10">
   <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="22fde2c3-8130-4dc4-9fe8-35daccde27e4" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="NGA-T-LSMOH" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-06-15" type="1"></activity-date>
  <activity-date iso-date="2020-06-15" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Jean NOUBOUSSI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>jean.nouboussi@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Jean NOUBOUSSI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>jean.nouboussi@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="NG" percentage="100">
   <narrative xml:lang="EN">Nigeria</narrative>
  </recipient-country>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="0.67" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="21.85" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="6.72" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="26.02" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="3.74" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="1.33" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="4.35" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="2F782C08-F342-42A0-ABA7-BD8E9C920F54" percentage="24.43" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Payment for Results</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="10.89" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">895922</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">1053145</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">944067</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">929044</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1063966</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">862267</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">749980</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">794348</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1146696</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">828678</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">787208</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">773532</value>
  </budget>
  <capital-spend percentage="6.72"></capital-spend>
  <transaction ref="5842c9cc-34da-45ed-8d90-1334a6832b8a">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-14"></transaction-date>
   <value currency="USD" value-date="2021-01-14">5318546.5</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="11c96eec-4372-4d36-a115-022d8682e154">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-26"></transaction-date>
   <value currency="USD" value-date="2021-02-26">268181.57</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="28ce4ea0-3c6d-4b5d-9b69-ba842257517e">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-27"></transaction-date>
   <value currency="USD" value-date="2021-02-27">-268181.57</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="cf7f210a-7029-45cb-90e6-0fa428a2c6c6">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-27"></transaction-date>
   <value currency="USD" value-date="2021-02-27">306333.57</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0f866407-accb-4822-b73c-875952946fbc">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-03-09"></transaction-date>
   <value currency="USD" value-date="2021-03-09">-306333.57</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4772909b-1409-4392-8dae-a8abf5319728">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-03-09"></transaction-date>
   <value currency="USD" value-date="2021-03-09">928147.41</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4786aeff-b5f2-4ef1-88e6-1c2b0d6cc645">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">-928147.41</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="68516607-3371-4ef3-9e8d-279730ee94bc">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">935315.39</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="be6a2ec5-3f3f-42a4-b55f-088029c6037f">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-06-17"></transaction-date>
   <value currency="USD" value-date="2021-06-17">693519.24</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="723646fb-76b9-438e-900d-d59f1192c061">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-07-02"></transaction-date>
   <value currency="USD" value-date="2021-07-02">-935315.39</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="1c3ec6ed-ff1f-4338-a7b0-57de73699dac">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-07-02"></transaction-date>
   <value currency="USD" value-date="2021-07-02">929407.32</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7071e5b2-308c-4c77-95d2-02c3a32cb66b">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-09-29"></transaction-date>
   <value currency="USD" value-date="2021-09-29">-664769.4</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="088259e1-6696-4f8f-8a27-5fc5ca0ed215">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-09-29"></transaction-date>
   <value currency="USD" value-date="2021-09-29">660978.62</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4ebc05d3-69de-4db7-befe-20829e5060ca">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-20"></transaction-date>
   <value currency="USD" value-date="2021-01-20">868401</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c602b11c-8450-4e10-9514-58c016ee1c84">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">757563.47</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c333c570-ac2d-484f-bfa1-ba9a768134ca">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-22"></transaction-date>
   <value currency="USD" value-date="2021-07-22">85899.4</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="d4cc191c-1654-4ff0-b6b0-1c81d8795a89">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-29"></transaction-date>
   <value currency="USD" value-date="2021-07-29">11385.5</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="5fd309ce-dece-492a-bae6-58a34672bcb6">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-25"></transaction-date>
   <value currency="USD" value-date="2021-08-25">178738.52</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-LSMOH.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">Lagos State Ministry of Health</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for NGA-T-LSMOH</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB/HIV mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 16</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 14</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 13</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 15</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 219</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 216</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 214</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 217</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB cases with RR-TB and/or MDR-TB</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 4.30</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.10</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.09</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.20</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for NGA-T-LSMOH</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 10937 Denominator: 11723 Percentage: 93.30</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1142 Denominator: 10937 Percentage: 10.44</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 4047 Denominator: 10937 Percentage: 37.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 6890 Denominator: 10937 Percentage: 63.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; community referrals</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 2070</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 10255</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 11138</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 11723</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 11723</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1224</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 244</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 4304</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 585</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 7419</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 108 Denominator: 347 Percentage: 31.12</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB regimen" value="New TB drugs"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 23 Denominator: 347 Percentage: 6.63</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 239 Denominator: 347 Percentage: 68.88</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB regimen" value="Short regimens"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 282 Denominator: 347 Percentage: 81.27</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 342 Denominator: 347 Percentage: 98.56</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 347</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 5 Denominator: 347 Percentage: 1.44</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; private/non-governmental facilities</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 2915</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 11 Denominator: 443 Percentage: 2.48</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 140 Denominator: 443 Percentage: 31.60</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 303 Denominator: 443 Percentage: 68.40</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 432 Denominator: 443 Percentage: 97.52</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 443</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of people in contact with TB patients who began preventive therapy</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="&lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 584 Denominator: 600 Percentage: 97.33</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 62 Denominator: 88 Percentage: 70.45</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 9433 Denominator: 11723 Percentage: 80.47</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 953 Denominator: 1224 Percentage: 77.86</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 443 Denominator: 9570 Percentage: 4.63</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 9127 Denominator: 9570 Percentage: 95.37</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 980 Denominator: 9570 Percentage: 10.24</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 81.00</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for NGA-T-LSMOH</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 60</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 134</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 145</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 153</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 24.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 66.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 70.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 61.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 77.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 82.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 87.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
